Literature DB >> 23336955

Increased serum HMGB1 related with HbA1c in coronary artery disease with type 2 diabetes mellitus.

Dongdong Zhao1, Yong Wang, Kai Tang, Yawei Xu.   

Abstract

Entities:  

Keywords:  Coronary artery disease; Glycosylated hemoglobin A1c; High mobility group box 1 protein; Type 2 diabetes mellitus

Mesh：

Substances：

Year:  2013        PMID： 23336955     DOI： 10.1016/j.ijcard.2012.12.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  10 in total

Review 1.  Unlocking the biology of RAGE in diabetic microvascular complications.

Authors:  Michaele B Manigrasso; Judyta Juranek; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Trends Endocrinol Metab       Date:  2013-09-03       Impact factor: 12.015

Review 2.  Serum glycated albumin is superior to hemoglobin A1c for correlating with HMGB1 in coronary artery disease with type 2 diabetic mellitus patients.

Authors:  Jianjun Yin; Daoqun Jin; Hong Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Depressed basal hypothalamic neuronal activity in type-1 diabetic mice is correlated with proinflammatory secretion of HMBG1.

Authors:  Jeffrey S Thinschmidt; Luis M Colon-Perez; Marcelo Febo; Sergio Caballero; Michael A King; Fletcher A White; Maria B Grant
Journal:  Neurosci Lett       Date:  2016-01-14       Impact factor: 3.046

4.  Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy.

Authors:  Namrita Kaur; Andrea Ruiz-Velasco; Rida Raja; Gareth Howell; Jessica M Miller; Riham R E Abouleisa; Qinghui Ou; Kimberly Mace; Susanne S Hille; Norbert Frey; Pablo Binder; Craig P Smith; Helene Fachim; Handrean Soran; Eileithyia Swanton; Tamer M A Mohamed; Oliver J Müller; Xin Wang; Jonathan Chernoff; Elizabeth J Cartwright; Wei Liu
Journal:  iScience       Date:  2022-02-23

Review 5.  High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications.

Authors:  Han Wu; Zheng Chen; Jun Xie; Li-Na Kang; Lian Wang; Biao Xu
Journal:  Mediators Inflamm       Date:  2016-10-25       Impact factor: 4.711

6.  Inhibiting HMGB1 Reduces Cerebral Ischemia Reperfusion Injury in Diabetic Mice.

Authors:  Chong Wang; Jie Jiang; Xiuping Zhang; Linjie Song; Kai Sun; Ruxiang Xu
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

7.  Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.

Authors:  Silvia Giovannini; Giovanni Tinelli; Federico Biscetti; Giuseppe Straface; Flavia Angelini; Dario Pitocco; Luciana Mucci; Raffaele Landolfi; Andrea Flex
Journal:  Cardiovasc Diabetol       Date:  2017-08-08       Impact factor: 9.951

Review 8.  Toll-like receptor 2 and type 2 diabetes.

Authors:  Zahra Sepehri; Zohre Kiani; Ali Akbar Nasiri; Farhad Kohan
Journal:  Cell Mol Biol Lett       Date:  2016-07-28       Impact factor: 5.787

9.  Sodium Butyrate Ameliorates Streptozotocin-Induced Type 1 Diabetes in Mice by Inhibiting the HMGB1 Expression.

Authors:  Yu Guo; Zheng Xiao; Yanan Wang; Weihua Yao; Shun Liao; Bo Yu; Jianqiang Zhang; Yanxiang Zhang; Bing Zheng; Boxu Ren; Quan Gong
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-25       Impact factor: 5.555

10.  Serum levels of the high-mobility group box 1 protein (HMGB1) in children with type 1 diabetes mellitus: case-control study.

Authors:  Igor Marjanac; Robert Lovrić; Jerko Barbić
Journal:  Cent Eur J Immunol       Date:  2019-04-15       Impact factor: 2.085
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.